Disease Info Card

Granular Cell Tumor

Information about Granular Cell Tumor: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Granular Cell Tumor

Most recent studies have shown that Granular Cell Tumor shares some biological mechanisms with benign-neoplasm, carcinoma, congenital-epulis, esophageal-neoplasms, gingival-neoplasms, gingival-polyp, hyperplasia, laryngeal-neoplasm, malignant-neoplasms, malignant-paraganglionic-neoplasm, mammary-neoplasms, myoblastoma, neoplasm-metastasis, neoplasms, neoplasms-multiple-primary, neoplasms-muscle-tissue, neurilemmoma, skin-neoplasms, soft-tissue-neoplasms, tongue-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Granular Cell Tumor, and have been seen in publications frequently: Aging, Angiogenesis, Autophagy, Cell Cycle, Cell Differentiation, Cell Proliferation, Enucleation, Hemostasis, Hormone Secretion, Keratinization, Localization, Mitosis, Pathogenesis, Phagocytosis, Pigmentation, Pinocytosis, Regeneration, Schwann Cell Differentiation, Secretion

Quite a number of genes have been found to play important roles in Granular Cell Tumor, such as CD68, CEACAM5, CEL, CTLA4, DES, ENO1, ENO2, GFAP, HLA-DQA1, LYZ, MB, MUC1, NOD2, S100A1, S100B, TP53, UCHL1, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.